S&P 500   5,060.35 (+1.58%)
DOW   38,884.88 (+0.71%)
QQQ   435.59 (+2.34%)
AAPL   183.27 (+0.52%)
MSFT   411.04 (+2.20%)
META   484.56 (+3.53%)
GOOGL   144.27 (+1.21%)
AMZN   172.14 (+2.11%)
TSLA   194.56 (-0.11%)
NVDA   776.33 (+15.06%)
NIO   5.81 (-2.68%)
AMD   178.09 (+8.40%)
BABA   75.41 (-0.22%)
T   16.67 (-1.94%)
F   12.20 (+0.49%)
MU   85.28 (+4.65%)
CGC   3.44 (+0.00%)
GE   151.22 (+1.44%)
DIS   108.25 (+0.54%)
AMC   4.66 (+1.97%)
PFE   27.35 (-1.16%)
PYPL   57.76 (+0.49%)
XOM   103.95 (-0.86%)
S&P 500   5,060.35 (+1.58%)
DOW   38,884.88 (+0.71%)
QQQ   435.59 (+2.34%)
AAPL   183.27 (+0.52%)
MSFT   411.04 (+2.20%)
META   484.56 (+3.53%)
GOOGL   144.27 (+1.21%)
AMZN   172.14 (+2.11%)
TSLA   194.56 (-0.11%)
NVDA   776.33 (+15.06%)
NIO   5.81 (-2.68%)
AMD   178.09 (+8.40%)
BABA   75.41 (-0.22%)
T   16.67 (-1.94%)
F   12.20 (+0.49%)
MU   85.28 (+4.65%)
CGC   3.44 (+0.00%)
GE   151.22 (+1.44%)
DIS   108.25 (+0.54%)
AMC   4.66 (+1.97%)
PFE   27.35 (-1.16%)
PYPL   57.76 (+0.49%)
XOM   103.95 (-0.86%)
S&P 500   5,060.35 (+1.58%)
DOW   38,884.88 (+0.71%)
QQQ   435.59 (+2.34%)
AAPL   183.27 (+0.52%)
MSFT   411.04 (+2.20%)
META   484.56 (+3.53%)
GOOGL   144.27 (+1.21%)
AMZN   172.14 (+2.11%)
TSLA   194.56 (-0.11%)
NVDA   776.33 (+15.06%)
NIO   5.81 (-2.68%)
AMD   178.09 (+8.40%)
BABA   75.41 (-0.22%)
T   16.67 (-1.94%)
F   12.20 (+0.49%)
MU   85.28 (+4.65%)
CGC   3.44 (+0.00%)
GE   151.22 (+1.44%)
DIS   108.25 (+0.54%)
AMC   4.66 (+1.97%)
PFE   27.35 (-1.16%)
PYPL   57.76 (+0.49%)
XOM   103.95 (-0.86%)
S&P 500   5,060.35 (+1.58%)
DOW   38,884.88 (+0.71%)
QQQ   435.59 (+2.34%)
AAPL   183.27 (+0.52%)
MSFT   411.04 (+2.20%)
META   484.56 (+3.53%)
GOOGL   144.27 (+1.21%)
AMZN   172.14 (+2.11%)
TSLA   194.56 (-0.11%)
NVDA   776.33 (+15.06%)
NIO   5.81 (-2.68%)
AMD   178.09 (+8.40%)
BABA   75.41 (-0.22%)
T   16.67 (-1.94%)
F   12.20 (+0.49%)
MU   85.28 (+4.65%)
CGC   3.44 (+0.00%)
GE   151.22 (+1.44%)
DIS   108.25 (+0.54%)
AMC   4.66 (+1.97%)
PFE   27.35 (-1.16%)
PYPL   57.76 (+0.49%)
XOM   103.95 (-0.86%)
NASDAQ:BYSI

BeyondSpring (BYSI) Stock Price, News & Analysis

$1.16
0.00 (0.00%)
(As of 10:07 AM ET)
Today's Range
$1.12
$1.16
50-Day Range
$0.85
$1.49
52-Week Range
$0.65
$2.07
Volume
9,997 shs
Average Volume
56,293 shs
Market Capitalization
$45.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.25

BeyondSpring MarketRank™ Stock Analysis

Analyst Rating
0.00 Rating Score
Upside/​Downside
7.8% Upside
$1.25 Price Target
Short Interest
Bearish
8.52% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.00 out of 5 stars

Medical Sector

932nd out of 932 stocks

Pharmaceutical Preparations Industry

429th out of 429 stocks


BYSI stock logo

About BeyondSpring Stock (NASDAQ:BYSI)

BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.

BYSI Stock Price History

BYSI Stock News Headlines

BeyondSpring Inc BYSI
Gold Could Be Heading for Record Highs - But How to Play It?
According to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold.
BeyondSpring Stock (NASDAQ:BYSI) Insider Trades
Oncternal slips after early data for lymphoma therapy
Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
BeyondSpring Files 2022 Annual Report on Form 20-F
See More Headlines
Receive BYSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BeyondSpring and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
12/29/2021
Today
2/22/2024
Next Earnings (Estimated)
4/16/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:BYSI
Employees
73
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.25
High Stock Price Target
$1.25
Low Stock Price Target
$1.25
Potential Upside/Downside
+7.8%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.35 million
Book Value
($0.36) per share

Miscellaneous

Free Float
27,515,000
Market Cap
$45.15 million
Optionable
Optionable
Beta
-0.13
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report














BYSI Stock Analysis - Frequently Asked Questions

What is BeyondSpring's stock price target for 2024?

0 Wall Street research analysts have issued 12-month price objectives for BeyondSpring's stock. Their BYSI share price targets range from $1.25 to $1.25. On average, they predict the company's stock price to reach $1.25 in the next year. This suggests a possible upside of 7.8% from the stock's current price.
View analysts price targets for BYSI
or view top-rated stocks among Wall Street analysts.

How have BYSI shares performed in 2024?

BeyondSpring's stock was trading at $0.90 at the beginning of the year. Since then, BYSI shares have increased by 28.9% and is now trading at $1.16.
View the best growth stocks for 2024 here
.

When is BeyondSpring's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 16th 2024.
View our BYSI earnings forecast
.

How were BeyondSpring's earnings last quarter?

BeyondSpring Inc. (NASDAQ:BYSI) released its quarterly earnings results on Wednesday, December, 29th. The company reported ($0.47) earnings per share for the quarter, topping the consensus estimate of ($0.58) by $0.11. The company had revenue of $0.34 million for the quarter, compared to analysts' expectations of $0.34 million.

What other stocks do shareholders of BeyondSpring own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BeyondSpring investors own include Exelixis (EXEL), Gilead Sciences (GILD), Sorrento Therapeutics (SRNE), AbbVie (ABBV), Enterprise Products Partners (EPD), Johnson & Johnson (JNJ), Pfizer (PFE), Atara Biotherapeutics (ATRA), Dynavax Technologies (DVAX).

When did BeyondSpring IPO?

(BYSI) raised $4 million in an initial public offering on Thursday, March 9th 2017. The company issued 200,000 shares at $20.00 per share. Rodman & Renshaw (a Unit of H.C. Wainwright & Co.) acted as the underwriter for the IPO.

Who are BeyondSpring's major shareholders?

BeyondSpring's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Decheng Capital LLC (12.74%), Capstone Capital Wealth Advisors (0.13%), Citadel Advisors LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of BeyondSpring?

Shares of BYSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BYSI) was last updated on 2/22/2024 by MarketBeat.com Staff